Generate a tailored SOP for Dr. Joshua Menke. Improve your application with a focused, well-structured draft.
Dr. Joshua Menke completed his hematopathology fellowship at Stanford and cytopathology fellowship at the University of California, San Francisco (UCSF). His clinical research interests lie at the intersection of hematopathology and cytopathology, focusing on advanced single-cell and cell-free diagnostic techniques. Currently, he serves as the Associate Section Director of Clinical Flow Cytometry at Stanford, where he is involved in developing and validating new minimal residual disease assays to detect low levels of myeloid and lymphoid neoplasms in the post-treatment setting. Dr. Menke is recognized for his research, having received the Paul E. Strandjord Young Investigator Award from the Academy of Clinical Laboratory Scientists and the Laurence J. Marton Award for Excellence in Research from UCSF for his translational work on CALR mutations at the UCSF Molecular Diagnostics Laboratory. He is also a founding member of the Cytology-Hematopathology Interinstitutional Collaboration (CHIC), which aims to study the performance of cytology samples in diagnosing lymphoma across large datasets from five academic institutions, and currently chairs the group, leading significant clinical research studies.
Stanford University • Stanford, CA
Associate Section Director of Clinical Flow Cytometry, involved in developing and validating diagnostic assays.
The Computer Science department emphasizes research potential. GRE General is currently optional but recommended for some tracks.